Nano Holdings, Inc. (TYO:4571)
Japan · Delayed Price · Currency is JPY 139.00
0.00 (0.00%)
At close: Feb 6, 2026
Nano Holdings Revenue
Nano Holdings had revenue of 34.00M JPY in the quarter ending September 30, 2025, with 385.71% growth. This brings the company's revenue in the last twelve months to 142.00M, up 178.43% year-over-year. In the fiscal year ending March 31, 2025, Nano Holdings had annual revenue of 108.00M, down -20.00%.
Revenue (ttm)
142.00M
Revenue Growth
+178.43%
P/S Ratio
73.75
Revenue / Employee
7.10M
Employees
20
Market Cap
10.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 108.00M | -27.00M | -20.00% |
| Mar 31, 2024 | 135.00M | -67.00M | -33.17% |
| Mar 31, 2023 | 202.00M | 84.18M | 71.45% |
| Mar 31, 2010 | 117.82M | -235.83M | -66.68% |
| Mar 31, 2009 | 353.65M | 90.93M | 34.61% |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.61B |
| CellSource | 3.71B |
| StemCell Institute | 2.72B |
| Immuno-Biological Laboratories | 1.01B |
| MEDINET | 998.00M |
| Stella Pharma | 992.00M |
| Chiome Bioscience | 727.99M |
| CellSeed | 161.00M |